1. Home
  2. VALN vs BBDC Comparison

VALN vs BBDC Comparison

Compare VALN & BBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$10.30

Market Cap

855.8M

Sector

Health Care

ML Signal

HOLD

Logo Barings BDC Inc.

BBDC

Barings BDC Inc.

HOLD

Current Price

$9.17

Market Cap

962.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VALN
BBDC
Founded
2012
2006
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Diversified Financial Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
855.8M
962.2M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
VALN
BBDC
Price
$10.30
$9.17
Analyst Decision
Strong Buy
Buy
Analyst Count
4
3
Target Price
$15.75
$9.67
AVG Volume (30 Days)
19.5K
559.3K
Earning Date
11-20-2025
02-19-2026
Dividend Yield
N/A
11.37%
EPS Growth
N/A
N/A
EPS
N/A
0.96
Revenue
$211,089,992.00
$281,866,000.00
Revenue This Year
$3.64
N/A
Revenue Next Year
$12.23
N/A
P/E Ratio
N/A
$9.49
Revenue Growth
13.48
N/A
52 Week Low
$4.56
$7.66
52 Week High
$12.25
$10.85

Technical Indicators

Market Signals
Indicator
VALN
BBDC
Relative Strength Index (RSI) 54.28 52.68
Support Level $9.62 $9.00
Resistance Level $10.32 $9.31
Average True Range (ATR) 0.30 0.16
MACD 0.03 -0.00
Stochastic Oscillator 62.50 54.37

Price Performance

Historical Comparison
VALN
BBDC

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About BBDC Barings BDC Inc.

Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. Barings employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.

Share on Social Networks: